Related Experiment Videos

The hyperreactive malarial splenomegaly syndrome in a European: has the treatment a modulatory effect on the immune

D C Betticher, A Nicole, P Pugin

The Journal of Infectious Diseases

|January 1, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.

ESMO open·2023

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.

ESMO open·2022

Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.

Journal of neuroinflammation·2016

Resilience and unmet supportive care needs in patients with cancer during early treatment: A descriptive study.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2015

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06).

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Circulating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19/05).

Lung cancer (Amsterdam, Netherlands)·2014

See all related articles